Publications

Schoen, MW, Basch, E, Hudson, LL, Chung, AE, Mendoza, TR, Mitchell, SA, St Germain, D, Baumgartner, P, Sit, L, Rogak, LJ, Shouery, M, Shalley, E, Reeve, BB, Fawzy, MR, Bhavsar, NA, Cleeland, C, Schrag, D, Dueck, AC, and Abernethy, AP. "Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study." Jmir Human Factors 5, no. 3 (July 16, 2018): e10070-null.

PMID
30012546
Full Text

Saha, A, Harowicz, MR, Cain, EH, Hall, AH, Hwang, E-SS, Marks, JR, Marcom, PK, and Mazurowski, MA. "Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival." Breast Cancer Research and Treatment (July 10, 2018).

PMID
29992418
Full Text

Hortobagyi, GN, Stemmer, SM, Burris, HA, Yap, YS, Sonke, GS, Paluch-Shimon, S, Campone, M, Petrakova, K, Blackwell, KL, Winer, EP, Janni, W, Verma, S, Conte, P, Arteaga, CL, Cameron, DA, Mondal, S, Su, F, Miller, M, Elmeliegy, M, Germa, C, and O'Shaughnessy, J. "Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer." Annals of Oncology : Official Journal of the European Society for Medical Oncology 29, no. 7 (July 2018): 1541-1547.

PMID
29718092
Full Text

Desjardins, A, Gromeier, M, Herndon, JE, Beaubier, N, Bolognesi, DP, Friedman, AH, Friedman, HS, McSherry, F, Muscat, AM, Nair, S, Peters, KB, Randazzo, D, Sampson, JH, Vlahovic, G, Harrison, WT, McLendon, RE, Ashley, D, and Bigner, DD. "Recurrent Glioblastoma Treated with Recombinant Poliovirus." The New England Journal of Medicine 379, no. 2 (July 2018): 150-161.

PMID
29943666
Full Text

Yu, Y, Suryo Rahmanto, Y, Lee, M-H, Wu, P-H, Phillip, JM, Huang, C-H, Vitolo, MI, Gaillard, S, Martin, SS, Wirtz, D, Shih, I-M, and Wang, T-L. "Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway." Oncogene 37, no. 28 (July 2018): 3778-3789.

PMID
29643476
Full Text

LaCroix, BL, Patierno, BM, Sullenger, BA, George, DJ, Patierno, SR, and Freedman, JA. "Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer." 10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Atlanta, GA. September 25, 2017 - September 28, 2017.: AMER ASSOC CANCER RESEARCH, July 1, 2018.

Scholars@Duke

LaCroix, BL, Patierno, BM, Sullenger, BA, George, DJ, Patierno, SR, and Freedman, JA. "Nutritional profiling reveals glutamine-utilizing transaminases as a metabolic vulnerability of TAZ/YAP-driven breast cancer cells." 10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Atlanta, GA. September 25, 2017 - September 28, 2017.: AMER ASSOC CANCER RESEARCH, July 1, 2018.

Scholars@Duke

Freedman, JA, Wang, Y, Li, X, Liu, H, Moorman, PG, George, DJ, Lee, NH, Hyslop, T, Wei, Q, and Patierno, SR. "Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival." Carcinogenesis 39, no. 7 (July 2018): 879-888.

PMID
29726910
Full Text

Secord, AA, Previs, RA, and Nixon, AB. "Cabozantinib in ovarian clear cell cancers: UnMET expectations." Gynecologic Oncology 150, no. 1 (July 2018): 1-2.

PMID
29935857
Full Text

Safe, S, Abbruzzese, J, Abdelrahim, M, and Hedrick, E. "Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development." Cancer Prevention Research (Philadelphia, Pa.) 11, no. 7 (July 2018): 371-382. (Review)

PMID
29545399
Full Text

Pages